These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28844089)

  • 21. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry.
    Konstantino Y; Haim M; Boxer J; Goldenberg I; Feldman A; Michowitz Y; Glikson M; Suleiman M;
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):718-23. PubMed ID: 26852908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.
    Roth GA; Poole JE; Zaha R; Zhou W; Skinner J; Morden NE
    J Am Coll Cardiol; 2016 Mar; 67(9):1062-1069. PubMed ID: 26940927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization trends and clinical outcomes in patients implanted with a single- vs a dual-coil implantable cardioverter-defibrillator lead: Insights from the ALTITUDE Study.
    Hsu JC; Saxon LA; Jones PW; Wehrenberg S; Marcus GM
    Heart Rhythm; 2015 Aug; 12(8):1770-5. PubMed ID: 25916569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of remote monitoring on long-term cardiovascular outcomes after cardioverter-defibrillator implantation.
    Portugal G; Cunha P; Valente B; Feliciano J; Lousinha A; Alves S; Braz M; Pimenta R; Delgado AS; Oliveira M; Ferreira RC
    Int J Cardiol; 2016 Nov; 222():764-768. PubMed ID: 27521554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
    Ambrosy AP; Parzynski CS; Friedman DJ; Fudim M; Hernandez AF; Fonarow GC; Masoudi FA; Al-Khatib SM
    Circulation; 2018 Dec; 138(24):2787-2797. PubMed ID: 30565983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers.
    Ruwald AC; Vinther M; Gislason GH; Johansen JB; Nielsen JC; Petersen HH; Riahi S; Jons C
    Eur J Heart Fail; 2017 Mar; 19(3):377-386. PubMed ID: 27905161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of appropriate interventions and mortality in patients with implantable cardioverter-defibrillators.
    Winkler A; Jaguś-Jamioła A; Uziębło-Życzkowska B; Orski Z; Krzyżanowski K; Smalc-Stasiak M; Kiliszek M
    Pol Arch Intern Med; 2019 Oct; 129(10):667-672. PubMed ID: 31498300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.
    Marynissen T; Floré V; Heidbuchel H; Nuyens D; Ector J; Willems R
    Europace; 2014 Jul; 16(7):1069-77. PubMed ID: 24196450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study.
    Dubner S; Valero E; Pesce R; Zuelgaray JG; Mateos JC; Filho SG; Reyes W; Garillo R
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):420-8. PubMed ID: 16255752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
    Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA
    Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of pacemaker dependence and pacemaker dependence as a predictor of mortality in patients with implantable cardioverter defibrillator.
    Sood N; Crespo E; Friedman M; Guertin D; Zweibel S; Kluger J; Clyne CA
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):945-51. PubMed ID: 23668483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience.
    Migliore F; Silvano M; Zorzi A; Bertaglia E; Siciliano M; Leoni L; De Franceschi P; Iliceto S; Corrado D
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):485-93. PubMed ID: 27136702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.
    Lee DS; Tu JV; Austin PC; Dorian P; Yee R; Chong A; Alter DA; Laupacis A
    J Am Coll Cardiol; 2007 Jun; 49(25):2408-15. PubMed ID: 17599603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic impact of pre-implantation hyponatremia on morbidity and mortality among patients with left ventricular dysfunction and implantable cardioverter-defibrillators.
    Bhavnani SP; Kumar A; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Europace; 2014 Jan; 16(1):47-54. PubMed ID: 23954920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.